SCHEMBL3978417

SCHEMBL3978417

COC(=O)CCc1ccc(OCCCOc2cccc(C(O)(C(F)(F)F)C(F)(F)F)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.51
NR1H3 Q13133 2/20 0.51
FAAH O00519 1/20 0.47
MLYCD O95822 1/20 0.44
FFAR1 O14842 3/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CACNA1B Q00975 2/20 0.42
CYP2D6 P10635 2/20 0.42
PLA2G4B P0C869 1/20 0.42
PPARD Q03181 4/20 0.42
VDR P11473 1/20 0.42
PPARG P37231 4/20 0.42
PPARA Q07869 3/20 0.42
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976043 0.89 NR1H2 (0.50) NR1H2NR1H3FAAHCACNA1BCYP2D6
SCHEMBL3980402 0.88 FFAR1 (0.58) NR1H2NR1H3FFAR1FFAR4PPARD
SCHEMBL3980366 0.83 NR1H2 (0.57) NR1H2NR1H3MLYCDFFAR1PPARD
SCHEMBL3983223 0.83 CACNA1B (0.44) NR1H2NR1H3FAAHCACNA1BCYP2D6
SCHEMBL3976505 0.82 PPARA (0.49) CACNA1BCYP2D6PPARGPPARA
SCHEMBL3984284 0.80 KDM4E (0.44) NR1H2NR1H3FAAHMLYCDCACNA1B
SCHEMBL10688441 0.78 MLYCD (0.60) NR1H2NR1H3MLYCD
SCHEMBL4513486 0.77 FFAR1 (0.64) FFAR1PPARGADRB2ADRB1
SCHEMBL3979033 0.76 NR1H2 (0.47) NR1H2NR1H3FAAHMLYCDCACNA1B
SCHEMBL18286160 0.76 KDM4E (0.57) FAAHCACNA1BCYP2D6PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7473705-B2 Hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. (US) 2009-01-06 US claimed
EP-1802566-B1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-11-26 EP claimed
EP-1802566-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-04 EP claimed
WO-2006037480-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-04-13 WO claimed
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. 2006-04-06 US claimed
US-7473705-B2 Hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. (US) 2009-01-06 US disclosed
EP-1802566-B1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-11-26 EP disclosed
EP-1802566-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-04 EP disclosed
WO-2006037480-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-04-13 WO disclosed
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives NR1H3, NR1H2, NR1I2 NR1H2 2/4885NR1H3 1/4885FAAH 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.